T22 "Manuscripts" (Part 1 of 2)

Item has been split into two parts. See SA/KET/A/1/6/9a for part two of item.

Comprises papers relating to Lancet submissions "Randomised Phase III Trial of Infliximab Combined with Ongoing Methotrexate in the Treatment of Rheumatoid Arthritis with Persistent Disease Activity" and "Anti-TNF Monoclonal Antibody Infliximab Combined with Ongoing Methotrexate Treatment of Rheumatoid arthritis” authored by Ravinder Maini and colleagues from the ATTRACT clinical trial.

The item contains working drafts, varied submissions and a copy of the final submission, correspondence, instructions from Ravinder Maini to collaborating authors, copies of data used in the article, data relating to adverse events, electronic submission statistics and author disclosures of interest.

1997- 2000

1 file (in 2 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.